Corcept Therapeutics

$23.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+0.98%) As of 1:19 PM EST today

Why Robinhood?

You can buy or sell CORT and other stocks, options, and ETFs commission-free!

About CORT

Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA. The listed name for CORT is Corcept Therapeutics Incorporated Common Stock.

CEO

Joseph K. Belanoff

Employees

206

Headquarters

Menlo Park, California

Founded

1998

Market Cap

2.74B

Price-Earnings Ratio

25.72

Dividend Yield

—

Average Volume

1.89M

High Today

$23.75

Low Today

$23.31

Open Price

$23.43

Volume

153.27K

52 Week High

$24.22

52 Week Low

$9.70

Collections

CORT Earnings

$0.00

$0.11

$0.23

$0.34

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 18, After Hours